DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Clarke NW, Ali A, Ingleby FC. et al.
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial.
Ann Oncol 2019;
30: 1992-2003
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.